Événements
École de recherche translationnelle en neurosciences
Le GIS Autisme et Troubles du Neuro-Développement (TND), l’Institut Thématique Neurosciences, Sciences Cognitives, Neurologie, Psychiatrie de l’Inserm et le CNRS Biologie organisent au Château de Suduiraut (Preignac, 33) du 13 au 16 mars 2025 une école de recherche translationnelle en neurosciences. Cette école s’adresse aux jeunes cliniciens (internes en neurologie, psychiatrie, neurochirurgie ou pharmacie), aux chercheurs post-doctorants, ainsi qu’aux chercheurs récemment recrutés dans les EPST ou Universités, désireux de se familiariser avec le monde de la recherche translationnelle. Elle sera cette année particulièrement dédiée au troubles du Neuro-Développement.
Candidatures ouvertes jusqu’au 31 octobre.
Informations pratiques
Lieu
Château de Suduiraut, 33210 Preignac
16th Göttingen Meeting of the German Neuroscience Society
The meeting takes place on March 26 – 29, 2025, in the town Göttingen in the heart of Germany. With around 1.300 participants it is one of the largest neuroscience meetings in Europe besides the FENS Forum. The program offers 36 symposia with four speakers each.
For more information please visit the website of the event.
Informations pratiques
Lieu
Göttingen, Germany
17th International Conference of the Society of Neuroscientists of Africa
This conference is a pivotal platform for exchanging scientific knowledge, innovative ideas, and expertise among African neuroscientists and worldwide. It aims to foster meaningful discussions and collaborations in fundamental and clinical neuroscience, specifically focusing on the intricate relationship between the Brain and the Environment.
The conference is scheduled for April 17-20, 2025 at the Cadi Ayyad University Conference Center in Marrakech, Morocco.
For more information, please visit the Conference website.
Informations pratiques
Lieu
Cadi Ayyad University Conference Center in Marrakech, Morocco.
CONFERENCE ON MULTIPLE SCLEROSIS
8.00 – 8.40: Registration
8.45 – 8.55: Welcome Address
9.00 – 9.45: Session 1 – Impact of environmental and biological factors on diseases course
Chair: TBC
9.00 – 9.15: Neural and immune biomarkers and course of MOGAD – Romain MARIGNIER (Lyon, FR)
9.15 – 9.30: Mediators of the link between socioeconomic status and disability progression in MS – Emmanuelle LERAY (Rennes, FR)
9.30 – 9.45: Impact of MS on individuals’ personal identity, memories and projections into the future – Alexandra ERNST (Paris, FR)
9.50 – 10.30: Session 2: What new about MS lesions imaging
Chair: TBD
9.50 – 10.05: Update on chronic active lesion and the central vein sign – Back to the MRI Workshop 2025 – TBD
10.05 – 10.20: Motor tract damage and relationship to functional disability in people with multiple sclerosis – Anne KERBRAT (Rennes, FR)
10.20 – 10.30 : FUSION4MS consortium – Adil MAAROUF (Marseille, FR)
10.30 – 11.00: COFFEE BREAK
11.00 – 12.00: Session 3 – 6 Short oral communications
Chair: Pierre-Olivier COURAUD (Paris, FR)
12.00 – 12.45: Session 4 – Keynote lecture
Chair: TBC
Immunological mechanisms in MS – present and future therapeutic impacts – Frauke ZIPP (Mainz, GER)
12.45 – 14.30: LUNCH BREAK & POSTER SESSION
14.30 – 15.30: Session 4: Role and interaction of the immune cells of the CNS
Chair: TBC
14.30 – 15.00: Cross-talk between follicular T cells and B cells in Multiple Sclerosis: exploring an intimate relationship – Laure MICHEL (Rennes, FR) & Nicolas FAZILLEAU (Toulouse, FR)
15.00 – 15.15: Identifying molecular targets to manipulate monocytes as a therapeutic strategy in multiple sclerosis – Elodie SEGURA (Paris, FR)
15.30 – 15.45: Therapeutic effect of IL-10-producing B cells in chronic autoimmune disease of the central nervous system: roles of microglia, macrophages, and astrocytes – Simon FILLATREAU (Paris, FR)
15.30 – 16.15: Session 6: Towards new therapeutic targets?
Chair: TBC
15.30 – 15.45: Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair – Carlos PARRAS (Paris, FR)
15.45 – 16.00: Usage of the molecule APRIL to combine anti-inflammatory and proregenerative actions in multiple sclerosis – Bertrand HUARD (Grenoble, FR)
16.00 – 16.15: Function and therapeutic targeting of the NF-kB2 transcription factor in experimental autoimmune encephalomyelitis – Yenkel GRINBERG-BLEYER (Lyon, FR)
16.15: Prizes of the best poster & the best short oral communication
Chairs: President and Vice-presidents of the scientific committee
16.30: End of the meeting
Organizing committee : Scientific Committee of ARSEP Foundation
Deadline for abstract submission (strongly recommended for those who have been granted): May 5, 2025
Deadline for registration (free but mandatory): June 6, 2024
Travel grants available for young researchers:
Information & Registration (online) : https://www.arsep.org/fr/337.html
Informations pratiques
Lieu
Institut des Cordeliers, Paris & Online